Depression
Authors: Tonya L. Fancher, Richard L. Kravitz
Journal: Annals of Internal Medicine (2010)

In the Clinic4 May 2010DepressionBarbara Turner, MD, MSED, Sankey Williams, MD, Darren Taichman, MD, PhD, Tonya L. Fancher, MD, and Richard L. Kravitz, MDBarbara Turner, MD, MSED, Sankey Williams, MD, Darren Taichman, MD, PhD, Tonya L. Fancher, MD, and Richard L. Kravitz, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-152-9-201005040-01005 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editor's Note: This issue of In the Clinic has been updated.Depression affects 5% to 10% of primary care patients (1) on average; however, this varies widely among clinical populations (2, 3). Only about half of depressed patients receive treatment (4). Untreated depression may prevent effective treatment of common co-occurring illnesses, such as diabetes (5). Depression causes disability similar to that of other chronic medical conditions (6, 7). Effective treatment reduces symptoms and improves quality of life (8). Asking about depression is sometimes viewed as "opening Pandora's box," but primary care clinicians can efficiently identify and manage most cases.Screening... References1. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-76. [PMID: 12020146] Google Scholar2. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934-42. [PMID: 10895843] Google Scholar3. Miranda J, Chung JY, Green BL, et al. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA. 2003;290:57-65. [PMID: 12837712] Google Scholar4. González HM, Vega WA, Williams DR, et al. Depression care in the United States: too little for too few. Arch Gen Psychiatry. 2010;67:37-46. [PMID: 20048221] Google Scholar5. Katon WJ, Schoenbaum M, Fan MY, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry. 2005;62:1313-20. [PMID: 16330719] Google Scholar6. Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11-9. [PMID: 7811158] Google Scholar7. Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002;167:1253-60. [PMID: 12451082] Google Scholar8. Heiligenstein JH, Ware JE Jr, Beusterien KM, et al. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. Int Psychogeriatr. 1995;7 Suppl:125-37. [PMID: 8580388] Google Scholar9. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry. 2003;54:363-75. [PMID: 12893111] Google Scholar10. Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry. 1999;56:322-7. [PMID: 10197826] Google Scholar11. Runeson B, Asberg M. Family history of suicide among suicide victims. Am J Psychiatry. 2003;160:1525-6. [PMID: 12900320] Google Scholar12. Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001;50:275-85. [PMID: 11570712] Google Scholar13. Person C, Tracy M, Galea S. Risk factors for depression after a disaster. J Nerv Ment Dis. 2006;194:659-66. [PMID: 16971817] Google Scholar14. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 2009;301:2462-71. [PMID: 19531786] Google Scholar15. O'Connor EA, Whitlock EP, Beil TL, et al. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med. 2009;151:793-803. [PMID: 19949145] Google Scholar16. Terre L, Poston WS, Foreyt J, et al. Do somatic complaints predict subsequent symptoms of depression? Psychother Psychosom. 2003;72:261-7. [PMID: 12920330] Google Scholar17. Whooley MA, Avins AL, Miranda J, et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12: 439-45. [PMID: 9229283] Google Scholar18. Mulrow CD, Williams JW Jr, Gerety MB, et al. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122:913-21. [PMID: 7755226] Google Scholar19. Diagnosis and Statisitical Manual of Mental Disorders 4th Edition. Washington, DC: American Pyschiatric Association; 1994. Google Scholar20. Beck AT, Steer RA, Brown GK. BDI-II, Beck Depression Inventory: Manual. 2nd ed. Boston: Harcourt-Brace; 1996. Google Scholar21. Georgiopoulos AM, Bryan TL, Yawn BP, et al. Population-based screening for postpartum depression. Obstet Gynecol. 1999;93:653-7. [PMID: 10912961] Google Scholar22. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24:709-11. [PMID: 3249773] Google Scholar23. Alexopoulos GS, Abrams RC, Young RC, et al. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23:271-84. [PMID: 3337862] Google Scholar24. Löwe B, Unützer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42:1194-201. [PMID: 15550799] Google Scholar25. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47-53. [PMID: 20051569] Google Scholar26. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54:1009-15. [PMID: 9366657] Google Scholar27. Depression in primary care: detection, diagnosis, and treatment. Agency for Healthcare Policy and Research. Clin Pract Guidel Quick Ref Guide Clin. 1993;5:1-20. Google Scholar28. Moscicki EK. Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am. 1997;20:499-517. [PMID: 9323310] Google Scholar29. Brody DS, Thompson TL 2nd, Larson DB, et al. Recognizing and managing depression in primary care. Gen Hosp Psychiatry. 1995;17:93-107. [PMID: 7789790] Google Scholar30. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294:2064-74. [PMID: 16249421] Google Scholar31. Vaiva G, Vaiva G, Ducrocq F, et al. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006;332:1241-5. [PMID: 16735333] Google Scholar32. Stanford EJ, Goetz RR, Bloom JD. The No Harm Contract in the emergency assessment of suicidal risk. J Clin Psychiatry. 1994;55:344-8. [PMID: 8071303] Google Scholar33. Garvey KA, Penn JV, Campbell AL, et al. Contracting for safety with patients: clinical practice and forensic implications. J Am Acad Psychiatry Law. 2009;37:363-70. [PMID: 19767501] Google Scholar34. Karch DL, Barker L, Strine TW. Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System. Inj Prev. 2006;12 Suppl 2:ii22-ii27. [PMID: 17170166] Google Scholar35. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53-9. [PMID: 12590624] Google Scholar36. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 2002;63:985-91. [PMID: 12444811] Google Scholar37. Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999;56:829-35. [PMID: 12884889] Google Scholar38. Fava GA, Rafanelli C, Grandi S, et al. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998;155:1443-5. [PMID: 9766780] Google Scholar39. Kessler D, Lewis G, Kaur S, et al. Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet. 2009;374:628-34. [PMID: 19700005] Google Scholar40. Warmerdam L, van Straten A, Twisk J, et al. Internet-based treatment for adults with depressive symptoms: randomized controlled trial. J Med Internet Res. 2008;10:e44. [PMID: 19033149] Google Scholar41. Clinical Efficacy Assessment Subcommittee of American College of Physicians. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;149:725-33. [PMID: 19017591] Google Scholar42. Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010:CD006117. [PMID: 20091586] Google Scholar43. Williams JW Jr, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132:743-56. [PMID: 10787370] Google Scholar44. STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-52. [PMID: 16554526] Google Scholar45. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67-74. [PMID: 7823648] Google Scholar46. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283:212-20. [PMID: 10634337] Google Scholar47. Dubicka B, Hadley S, Roberts C. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry. 2006;189:393-8. [PMID: 17077427] Google Scholar48. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880. [PMID: 19671933] Google Scholar49. Grunebaum MF, Ellis SP, Li S, et al. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry. 2004;65:1456-62. [PMID: 15554756] Google Scholar50. Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006;354:1130-8. [PMID: 16540613] Google Scholar51. Spier SA. Use of bupropion with SRIs and venlafaxine. Depress Anxiety. 1998;7:73-5. [PMID: 9614595] Google Scholar52. Carpenter LL, Jocic Z, Hall JM, et al. Mirtazapine augmentation in the treatment of refractory depression. J Clin Psychiatry. 1999;60:45-9. [PMID: 10074878]. Google Scholar53. Shelton RC, Papakostas GI. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Acta Psychiatr Scand. 2008;117:253-9. [PMID: 18190674] Google Scholar54. Candy M, Jones L, Williams R, et al. Psychostimulants for depression. Cochrane Database Syst Rev. 2008:CD006722. [PMID: 18425966] Google Scholar55. Hardy SE. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother. 2009;7:34-59. [PMID: 19281939] Google Scholar56. Obrocea G. Thyroid hormone augmentation in treatment resistant depression. Clin Pyschopharmacol Neurosci. 2008;6:3-10 Google Scholar57. Cooper-Kazaz R, Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol. 2008;11:685-99. [PMID: 18047754] Google Scholar58. Carney RM, Freedland KE, Rubin EH, et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009;302:1651-7. [PMID: 19843899] Google Scholar59. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162:656-62. [PMID: 15800134] Google Scholar60. Mead GE, Morley W, Campbell P, et al. Exercise for depression. Cochrane Database Syst Rev. 2009:CD004366. [PMID: 19588354] Google Scholar61. Morgan AJ, Jorm AF. Self-help interventions for depressive disorders and depressive symptoms: a systematic review. Ann Gen Psychiatry. 2008;7:13. [PMID: 18710579] Google Scholar62. Nurnberg HG, Hensley PL. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. CNS Spectr. 2003;8:194-202. [PMID: 12595814] Google Scholar63. Wright SK, Schroeter S. Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract. 2008;20:47-51. [PMID: 18184165] Google Scholar64. Osteoporotic Fractures in Men Study Group. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007;167:1246-51. [PMID: 17592097] Google Scholar65. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med. 2009;169:2128-39. [PMID: 20008698] Google Scholar66. O'Connor CM, Jiang W, Kuchibhatla M, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168:2232-7. [PMID: 19001200] Google Scholar67. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008:CD000448. [PMID: 18843608] Google Scholar68. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther. 2000;294:88-95. [PMID: 10871299] Google Scholar69. de Maat MM, Hoetelmans RM, Math RA, et al. Drug interaction between St John's wort and nevirapine. AIDS. 2001;15:420-1. [PMID: 11273226] Google Scholar70. Ondrizek RR, Chan PJ, Patton WC, et al. Inhibition of human sperm motility by specific herbs used in alternative medicine. J Assist Reprod Genet. 1999;16:87-91. [PMID: 10079411] Google Scholar71. Pies R. Handbook of Essential Psychopharmacology, second ed. American Psychiatric Publishing; 2005. Google Scholar72. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-87. [PMID: 16467545] Google Scholar73. U.S. Food and Drug Administration. FDA Public Health Advisory: Treatment Challenges of Depression in Pregnancy. 2006. Accessed at www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm124348.htm on 25 March 2010. Google Scholar74. Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry. 2008;165:749-52. [PMID: 18381907] Google Scholar75. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507. [PMID: 16449615] Google Scholar76. Miller LJ. Psychiatric medication during pregnancy: understanding and minizing risks. Psychiatr Ann. 1994;24:69-75. Google Scholar77. Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry. 2000;61 Suppl 2:6-9. [PMID: 10714617] Google Scholar78. Ong MK, Rubenstein LV. Wishing upon a STAR*D: the promise of ideal depression care by primary care providers. Psychiatr Serv. 2009;60:1460-2. [PMID: 19880461] Google Scholar79. Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166:2314-21. [PMID: 17130383] Google Scholar80. Weissman MM, Olfson M. Translating intergenerational research on depression into clinical practice. JAMA. 2009;302:2695-6. [PMID: 20040558] Google Scholar81. Gilbody S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ. 2008;178:997-1003. [PMID: 18390942] Google Scholar82. Unutzer J, Katon WJ, Fan MY, et al. Long-term cost effects of collaborative care for late-life depression. Am J Manag Care. 2008;14:95-100. [PMID: 18269305] Google Scholar83. Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Database Syst Rev. 2006;3:CD001025. [PMID: 16855955] Google Scholar84. Sherbourne CD, Wells KB, Duan N, et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry. 2001;58:696-703. [PMID: 11448378] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPsychopharmacologyMajor Depression 4 May 2010Volume 152, Issue 9Page: ITC5-1KeywordsBehaviorDepressionDiagnostic and Statistical Manual of Mental Disorders fourth editionDrugsFood and Drug AdministrationHospitalizationsPatientsPregnancySelective serotonin reuptake inhibitorsSuicide ePublished: 4 May 2010 Issue Published: 4 May 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...